The University of Glasgow and Kadans Science Partner, supported by Scottish Enterprise, are delighted to announce the construction of a new Health Innovation Hub in Govan, setting the stage for a thriving life sciences cluster in the area.
Work on the new Health Innovation Hub has begun, and is due for completion in summer 2025. Morrison Construction have been appointed as the main contractor. The Hub will attract new innovative businesses into the area, and deliver local benefits to the community through job creation.
The Hub is a flagship investment within the University’s Glasgow Riverside Innovation District (GRID). It will be home to commercial businesses as well as the University of Glasgow-led Living Laboratory for Precision Medicine – an internationally leading programme supported by UKRI Strength in Places Funding, which is focused on translating cutting edge research and healthcare innovation into a real-world clinical setting. A key aspect of the programme will be to enhance collaboration and partnerships between academia, industry, clinicians and the community in order to better tackle healthcare challenges for the benefit of patients and the NHS. It is hoped the world-leading work carried out here will go on to help address some of the biggest healthcare challenges faced nationally and globally.
Designed to be highly flexible, the Hub includes both laboratory and office space for life science and health businesses, with research links to both the University of Glasgow and the Queen Elizabeth University Hospital. There will be an accessible ground floor, with a café and collaboration space, to create a useable space for the local community. The building will also be home to a ‘Digital Health Validation Lab,’ which will enhance the evaluation and validation of digital health technologies for clinical use, accelerating their adoption into clinical practice.
Professor Iain McInnes, University of Glasgow Vice-Principal and Head of the College of Medical, Veterinary & Life Sciences, said: “The University and Kadans Health Innovation Hub will be the cornerstone of our UKRI Strength in Places-funded Living Laboratory for Precision Medicine.
“The world-class facilities created here will be key to the supportive and dynamic ecosystem that brings together academics, industry partners and the NHS to achieve this goal. The Health Innovation Hub will be a catalyst for collaboration and innovation to better tackle global healthcare challenges, bringing real-world benefits to patients and the NHS.”
Uzma Khan, Vice Principal of Economic Development and Innovation at the University of Glasgow said: “We are proud to be partnering with Kadans Science Partner and supported by Scottish Enterprise to deliver the Health Innovation Hub in Govan. This is a hugely exciting project which speaks to our ambitions to expand the life sciences cluster in Govan, and our mission as a civic university.
“As a flagship project for the Glasgow Riverside Innovation District, we will commit to working closely with the community and with key stakeholders such as Clyde College, to ensure benefits are meaningful and delivered locally, and to capitalise on the opportunities for new employment and growth for Govan and across Glasgow”.
James Dawson, Development Manager at Kadans Science Partner said: “We are delighted to be beginning construction on our new Health Innovation Hub. Along with our existing facilities at West of Scotland Science Park, this project cements Glasgow and in particular the communities of Govan and Linthouse, as key pillars in our UK growth strategy.
Partnering with the University of Glasgow and with support from Scottish Enterprise, we look forward to collaborating on the future success of the Health Innovation Hub.”
NOTES
- An architect image of the Health Innovation Hub can be found here. Caption details: The Health Innovation Hub in Govan.
- The Living Laboratory for Precision Medicine was announced in June 2020 as one of the seven successful bids to wave 1 of the UK Research and Innovation Strength in Places Fund (SiPF). The project brings together a collaboration of partners to address the biggest challenge currently facing precision medicine: the adoption of healthcare innovations into clinical practice for the benefit of patients. The project will cement Glasgow as a global leader in precision medicine, delivering savings for the NHS, improving health outcomes and driving economic development in Govan, Glasgow, across Scotland and beyond.
- The Glasgow Riverside Innovation District (GRID) is a partnership between the University of Glasgow, Scottish Enterprise and Glasgow City Council and is Scotland’s first whole-system demonstrator, committed to supporting the establishment of a series of real-world innovation testbeds.
- GRID aims to create an environment which will boost existing collaborations with industry and encourage the formation of new ones. Encompassing both banks of the River Clyde, GRID offers the city the chance to reimagine its proud industrial heritage for the 21st century and to establish Glasgow’s leadership in the industries of the future.
- Precision Medicine is a new generation of healthcare delivery which signifies a movement away from a one-size-fits-all approach to medical care, tailoring medical diagnosis and treatment to the individual characteristics of patients. Through the development of cutting-edge tools and innovations such as medical imaging, genomics and artificial intelligence, precision medicine can be used to help treat people quickly and more successfully whilst avoiding unnecessary side effects from treatments that may not be effective
- About Kadans Science Partner
Kadans Science Partner is the European leader investing in the development of ecosystems and real estate with a dedicated focus on the knowledge intensive sector. Kadans has invested across various specific areas, like agri-tech in Wageningen, life sciences in Leiden, and cell & gene therapy in Stevenage, UK. Kadans provides its tenants with an array of additional services tailored to their specific needs. In December 2020, Kadans was acquired by AXA IM Alts, which, as a long- term capital partner, has allowed us to significantly accelerate our growth.
Kadans is currently present on 26 campuses, in 6 countries, where it operates over 7 million sq ft of space for over 400 tenants, including start-ups, scale-ups, corporates, government bodies and educational institutes. Kadans has a solid view of the developments our tenants and partners are currently working on and which parties in our network could benefit from connecting.
Instagram: @kadanssciencepartner
Twitter: @KadansScience
- Morrison Construction is a trading name of Galliford Try Holdings plc, a leading UK construction group listed on the London Stock Exchange. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure projects with clients in the public, private and regulated sectors across the UK.
ENDS